Vitamin K antagonists [phsu]
Heparin, Low-Molecular-Weight [carb, phsu]
Long-term [tmco]
treatment [ftcn]
Symptomatic [ftcn]
Venous Thromboembolism [patf]
Background [cnce]
People [popg]
Venous Thromboembolism [patf]
vte [orch]
treated [topp]
FIVE-DAY [inpr]
Intravenous heparin [carb, phsu]
subcutaneous [spco]
Heparin, Low-Molecular-Weight [carb, phsu]
Three [qnco]
months [tmco]
vitamin k antagonist [topp]
treatment [ftcn]
treatment [ftcn]
Vitamin K antagonists [phsu]
Regular [qlco]
laboratory measurements [resa]
Patients [podg]
contraindications [qlco]
treatment [ftcn]
This [euka]
Update [tmco]
Review [inpr]
First [qnco]
Published [ocac]
Update [tmco]
objectives [inpr]
To [qlco]
Evaluate [ftcn]
Efficacy [qlco]
Safety [hcpp]
long-term treatment [hlca]
vte [orch]
Heparin, Low-Molecular-Weight [carb, phsu]
Compared [acty]
Vitamin K antagonists [phsu]
search [inpr]
Methods [inpr]
Update [tmco]
Peripheral Vascular Diseases [dsyn]
Group [idcn]
Trial [resa]
search [inpr]
Searched [acty]
specialised [qlco]
Last [qlco]
Searched [acty]
Central [spco]
Issue [fndg]
Selection Criteria [qlco]
Two [qnco]
Authors [prog]
Evaluated [ftcn]
Trial [resa]
methodology [inpr]
Quality [qlco]
Data Collection [resa]
Analysis [lbpr]
Review [inpr]
Authors [prog]
Extracted [topp]
Data [idcn]
Primary [qlco]
Analysis [lbpr]
included [ftcn]
Trial [resa]
participants [popg]
treatment [ftcn]
Group [idcn]
Separate [spco]
Analysis [lbpr]
Performed [ftcn]
Quality [qlco]
Trial [resa]
subgroups [virs]
Trial [resa]
Initially [tmco]
Using [ftcn]
Similar [qlco]
Treatments [topp]
Trial Arms [idcn]
Not [ftcn]
Trial [resa]
Concern [idcn]
Deep Vein Thrombosis [dsyn]
Pulmonary Embolism [dsyn]
Different [qlco]
Follow-up [fndg]
Main [qlco]
Result [ftcn]
Trial [resa]
Combined [qlco]
Patients [podg]
Fulfill [idcn]
criteria [inpr]
Combined [qlco]
Meta-Analysis [inpr]
Found [qnco]
Non [ftcn]
statistically significant [qnco]
reduction [npop]
Risk [qlco]
Recurrent [tmco]
vte [orch]
Two [qnco]
Treatments [topp]
Odds Ratio [qnco]
Analysis [lbpr]
Pooled [cnce]
Data [idcn]
Category [inpr]
I- [inch]
Trial [resa]
High [qlco]
methodology [inpr]
Quality [qlco]
Show [inpr]
Non [ftcn]
reduction [npop]
Recurrent [tmco]
vte [orch]
Heparin, Low-Molecular-Weight [carb, phsu]
treatment [ftcn]
Odds Ratio [qnco]
Trial [resa]
Combined [qlco]
Bleeding [patf]
treatment [ftcn]
Heparin, Low-Molecular-Weight [carb, phsu]
Odds Ratio [qnco]
Only [qnco]
Category [inpr]
I- [inch]
Trial [resa]
Non [ftcn]
trend [tmco]
Heparin, Low-Molecular-Weight [carb, phsu]
Odds Ratio [qnco]
Observed [ftcn]
Mortality [qnco]
Odds Ratio [qnco]
Authors [prog]
Conclusions [idcn]
LMWH [carb, phsu]
Possibly [qlco]
effective [qlco]
Vitamin K antagonists [phsu]
PREVENT [phsu]
Symptomatic [ftcn]
vte [orch]
Episode [tmco]
Symptomatic [ftcn]
Deep-Venous Thrombosis [dsyn]
expense [qnco]
treatment [ftcn]
Heparin, Low-Molecular-Weight [carb, phsu]
Safeties [hcpp]
treatment [ftcn]
Vitamin K antagonists [phsu]
Heparin, Low-Molecular-Weight [carb, phsu]
Result [ftcn]
Few [qnco]
Episodes [tmco]
Bleeding [patf]
Possibly [qlco]
Alternative [cnce]
Patients [podg]
Reluctant [menp]
Visit [bhvr]
Thrombosis [patf]
Service [ocac]
contraindications [qlco]
Vitamin K antagonists [phsu]
treatment [ftcn]
Vitamin K antagonists [phsu]
treatment [ftcn]
choice [inbe]
majority [socb]
Patients [podg]
